Description

Prandial M 0. 3 Tablet is a medicine that contains a combination of two active ingredients, Metformin and Voglibose. Metformin is an oral medication used to treat type 2 diabetes by reducing blood sugar levels. It works by improving the body’s response to insulin and decreasing the amount of glucose produced by the liver. Voglibose, on the other hand, is an alpha-glucosidase inhibitor that delays the digestion and absorption of carbohydrates, thereby reducing postprandial blood glucose levels. Prandial M 0. 3 Tablet is primarily prescribed for individuals with type 2 diabetes to control their blood sugar levels. It is a valuable addition to the treatment regimen for patients who struggle to manage their blood glucose levels through lifestyle modifications alone. By combining the benefits of Metformin and Voglibose, Prandial M 0. 3 Tablet helps improve glycemic control, leading to better management of diabetes and prevention of further complications.

Additional information